KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,094 | -39.5% | 1,805,346 | 0.0% | 1.08% | -16.3% |
| Q2 2023 | $41,505 | -22.4% | 1,805,346 | 0.0% | 1.29% | -59.5% |
| Q1 2023 | $53,492 | +7.2% | 1,805,346 | -9.7% | 3.18% | +14.1% |
| Q4 2022 | $49,920 | -99.8% | 2,000,000 | +33.3% | 2.79% | +99.9% |
| Q3 2022 | $32,655,000 | +65.8% | 1,500,000 | +50.0% | 1.39% | +32.5% |
| Q2 2022 | $19,690,000 | -53.5% | 1,000,000 | 0.0% | 1.05% | -40.6% |
| Q1 2022 | $42,320,000 | -33.3% | 1,000,000 | 0.0% | 1.77% | +2.8% |
| Q4 2021 | $63,490,000 | +170.2% | 1,000,000 | +150.0% | 1.72% | +227.6% |
| Q3 2021 | $23,496,000 | +93.8% | 400,000 | +60.0% | 0.53% | +113.8% |
| Q2 2021 | $12,125,000 | +24.8% | 250,000 | 0.0% | 0.25% | +43.0% |
| Q1 2021 | $9,715,000 | -37.3% | 250,000 | 0.0% | 0.17% | -48.3% |
| Q4 2020 | $15,500,000 | +91.9% | 250,000 | 0.0% | 0.33% | +69.9% |
| Q3 2020 | $8,078,000 | – | 250,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |